bookoff-mcandrews
googleplus--white
linkedin--white
noun_Conversation_1010437
vcard
close
Search for:
Home
Our Team
About Us
Practice Areas
Back
Practice Areas
Patent Prosecution & Portfolio Management
Due Diligence & IP Transactions
Opinions & Counseling
Contested Proceedings
Industry Experience
Back
Industry Experience
Mechanical
Medical Devices & Healthcare IT
Computer & Electrical
Chemistry & Materials
Software & Internet
Consumer Products
Pharmaceuticals & Biotechnology
Manufacturing & Transportation
Energy & Cleantech
Join Us
Contact Us
Diversity
Blog
News
Bookoff McAndrews
Our Team
About Us
Practice Areas
Industry Experience
Join Us
Contact Us
Diversity
Blog
News
Search for:
Blog
January 25, 2019
Secret Sales Remain Prior Art Under the AIA: Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA Inc.
Read More
January 9, 2019
When Double Patenting Rejections are Not Obvious: Novartis v. Breckenridge and Novartis v. Ezra
Kirsten Johnson
Read More
November 7, 2018
Patent Strategies for Beta Testing: Leveraging Provisional Patent Applications to Preserve Patent Rights for Beta Features
Aaron Johnson
Read More
October 11, 2018
PTAB Revises Claim Construction Standard
Dinesh N. Melwani
Read More
October 4, 2018
PTAB Publishes AIA Trial Practice Guide Update
Jason B. Portis
Read More
June 21, 2018
Patent-Eligibility of “Methods of Treatment,” and Possible Movement Toward Greater Eligibility
Aaron Johnson
Read More
May 2, 2018
Supreme Court Strikes Down PTAB Partial-Institution Practice—SAS Institute v. Iancu
Read More
April 20, 2018
USPTO Releases Updated Patent-Eligibility Guidance Favorable to Patent Applicants
Chris Agrawal
Read More
April 19, 2018
Hope for Clarification of the On-Sale Bar on the Horizon
Jessica F. Winchester
Read More
April 12, 2018
PTAB to Reconsider its Indefiniteness Standard?
Read More
«
« prev
1
2
3
4
5
6
7
8
9
10
11
12
13
next »
»